Compounds useful for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9108919
SERIAL NO

14087762

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of preventing, inhibiting, or treating cancer that includes contacting a cell with at least one compound of formula (Ia) or a pharmaceutically acceptable salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABIVAX;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSTITUT CURIE;UNIVERSITE DE MONTPELLIER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brock, Carsten Montpellier, FR 9 65
Cahuzac, Nathalie Jacou, FR 9 65
Gadea, Gilles Matelles, FR 15 65
Mahuteau, Florence Saint Remy les Chevreuse, FR 29 182
Najman, Romain L'Hay les Roses, FR 38 193
Roux, Pierre Saint-Gely-du-Fesc, FR 55 516
Scherrer, Didier Castelnau le Lez, FR 46 194
Tazi, Jamal Clapiers, FR 50 248

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 18, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00